306 related articles for article (PubMed ID: 26138826)
1. RNA Editing of the GP Gene of Ebola Virus is an Important Pathogenicity Factor.
Volchkova VA; Dolnik O; Martinez MJ; Reynard O; Volchkov VE
J Infect Dis; 2015 Oct; 212 Suppl 2():S226-33. PubMed ID: 26138826
[TBL] [Abstract][Full Text] [Related]
2. Soluble Glycoprotein Is Not Required for Ebola Virus Virulence in Guinea Pigs.
Hoenen T; Marzi A; Scott DP; Feldmann F; Callison J; Safronetz D; Ebihara H; Feldmann H
J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S242-6. PubMed ID: 25957965
[TBL] [Abstract][Full Text] [Related]
3. Genomic RNA editing and its impact on Ebola virus adaptation during serial passages in cell culture and infection of guinea pigs.
Volchkova VA; Dolnik O; Martinez MJ; Reynard O; Volchkov VE
J Infect Dis; 2011 Nov; 204 Suppl 3():S941-6. PubMed ID: 21987773
[TBL] [Abstract][Full Text] [Related]
4. Recovery of infectious Ebola virus from complementary DNA: RNA editing of the GP gene and viral cytotoxicity.
Volchkov VE; Volchkova VA; Muhlberger E; Kolesnikova LV; Weik M; Dolnik O; Klenk HD
Science; 2001 Mar; 291(5510):1965-9. PubMed ID: 11239157
[TBL] [Abstract][Full Text] [Related]
5. Ebola Virus GP Gene Polyadenylation Versus RNA Editing.
Volchkova VA; Vorac J; Repiquet-Paire L; Lawrence P; Volchkov VE
J Infect Dis; 2015 Oct; 212 Suppl 2():S191-8. PubMed ID: 25838269
[TBL] [Abstract][Full Text] [Related]
6. Shedding of Ebola Virus Surface Glycoprotein Is a Mechanism of Self-regulation of Cellular Cytotoxicity and Has a Direct Effect on Virus Infectivity.
Dolnik O; Volchkova VA; Escudero-Perez B; Lawrence P; Klenk HD; Volchkov VE
J Infect Dis; 2015 Oct; 212 Suppl 2():S322-8. PubMed ID: 26092855
[TBL] [Abstract][Full Text] [Related]
7. VP24 is a molecular determinant of Ebola virus virulence in guinea pigs.
Mateo M; Carbonnelle C; Reynard O; Kolesnikova L; Nemirov K; Page A; Volchkova VA; Volchkov VE
J Infect Dis; 2011 Nov; 204 Suppl 3():S1011-20. PubMed ID: 21987737
[TBL] [Abstract][Full Text] [Related]
8. A new Ebola virus nonstructural glycoprotein expressed through RNA editing.
Mehedi M; Falzarano D; Seebach J; Hu X; Carpenter MS; Schnittler HJ; Feldmann H
J Virol; 2011 Jun; 85(11):5406-14. PubMed ID: 21411529
[TBL] [Abstract][Full Text] [Related]
9. Molecular characterization of guinea pig-adapted variants of Ebola virus.
Volchkov VE; Chepurnov AA; Volchkova VA; Ternovoj VA; Klenk HD
Virology; 2000 Nov; 277(1):147-55. PubMed ID: 11062045
[TBL] [Abstract][Full Text] [Related]
10. The Roles of Ebola Virus Soluble Glycoprotein in Replication, Pathogenesis, and Countermeasure Development.
Zhu W; Banadyga L; Emeterio K; Wong G; Qiu X
Viruses; 2019 Oct; 11(11):. PubMed ID: 31683550
[TBL] [Abstract][Full Text] [Related]
11. Functional Characterization of Adaptive Mutations during the West African Ebola Virus Outbreak.
Dietzel E; Schudt G; Krähling V; Matrosovich M; Becker S
J Virol; 2017 Jan; 91(2):. PubMed ID: 27847361
[TBL] [Abstract][Full Text] [Related]
12. Elucidating variations in the nucleotide sequence of Ebola virus associated with increasing pathogenicity.
Dowall SD; Matthews DA; Garcia-Dorival I; Taylor I; Kenny J; Hertz-Fowler C; Hall N; Corbin-Lickfett K; Empig C; Schlunegger K; Barr JN; Carroll MW; Hewson R; Hiscox JA
Genome Biol; 2014; 15(11):540. PubMed ID: 25416632
[TBL] [Abstract][Full Text] [Related]
13. Structures of Ebola virus GP and sGP in complex with therapeutic antibodies.
Pallesen J; Murin CD; de Val N; Cottrell CA; Hastie KM; Turner HL; Fusco ML; Flyak AI; Zeitlin L; Crowe JE; Andersen KG; Saphire EO; Ward AB
Nat Microbiol; 2016 Aug; 1(9):16128. PubMed ID: 27562261
[TBL] [Abstract][Full Text] [Related]
14. VSVΔG/EBOV GP-induced innate protection enhances natural killer cell activity to increase survival in a lethal mouse adapted Ebola virus infection.
Williams KJ; Qiu X; Fernando L; Jones SM; Alimonti JB
Viral Immunol; 2015 Feb; 28(1):51-61. PubMed ID: 25494457
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity of propagation-restricted vesicular stomatitis virus encoding Ebola virus glycoprotein in guinea pigs.
Locher S; Schweneker M; Hausmann J; Zimmer G
J Gen Virol; 2018 Jul; 99(7):866-879. PubMed ID: 29869979
[TBL] [Abstract][Full Text] [Related]
16. Less is more: Ebola virus surface glycoprotein expression levels regulate virus production and infectivity.
Mohan GS; Ye L; Li W; Monteiro A; Lin X; Sapkota B; Pollack BP; Compans RW; Yang C
J Virol; 2015 Jan; 89(2):1205-17. PubMed ID: 25392212
[TBL] [Abstract][Full Text] [Related]
17. Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury.
Yang ZY; Duckers HJ; Sullivan NJ; Sanchez A; Nabel EG; Nabel GJ
Nat Med; 2000 Aug; 6(8):886-9. PubMed ID: 10932225
[TBL] [Abstract][Full Text] [Related]
18. Genetic Changes at the Glycoprotein Editing Site Associated With Serial Passage of Sudan Virus.
Alfson KJ; Avena LE; Beadles MW; Menzie H; Patterson JL; Carrion R; Griffiths A
J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S295-304. PubMed ID: 25920319
[TBL] [Abstract][Full Text] [Related]
19. [Research progress on ebola virus glycoprotein].
Ding GY; Wang ZY; Gao L; Jiang BF
Bing Du Xue Bao; 2013 Mar; 29(2):233-7. PubMed ID: 23757858
[TBL] [Abstract][Full Text] [Related]
20. The Ebola virus soluble glycoprotein contributes to viral pathogenesis by activating the MAP kinase signaling pathway.
Furuyama W; Shifflett K; Feldmann H; Marzi A
PLoS Pathog; 2021 Sep; 17(9):e1009937. PubMed ID: 34529738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
